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Garth D Ehrlich2 and Peter-John Wormald1,3*Abstract
Background: Bacteria and fungi are believed to influence mucosal inflammation in chronic rhinosinusitis (CRS).
However their presence and relationship to disease is debated. This study used multiple detection methods to
compare microbial diversity and microbial abundance in healthy and diseased sinonasal mucosa. The utility of
contemporary detection methods is also examined.
Methods: Sinonasal mucosa was analyzed from 38 CRS and 6 controls. Bacterial and fungal analysis was performed
using conventional culture, molecular diagnostics (polymerase chain reaction coupled with electrospray ionization
time-of-flight mass spectrometry) and fluorescence in situ hybridization.
Results: Microbes were detected in all samples, including controls, and were often polymicrobial. 33 different
bacterial species were detected in CRS, 5 in control patients, with frequent recovery of anaerobes. Staphylococcus
aureus and Propionibacterium acnes were the most common organisms in CRS and controls, respectively. Using a
model organism, FISH had a sensitivity of 78%, and a specificity of 93%. Many species were detected in both CRS
and controls however, microbial abundance was associated with disease manifestation.
Conclusions: This study highlights some cornerstones of microbial variations in healthy and diseased paranasal
sinuses. Whilst the healthy sinus is clearly not sterile, it appears prevalence and abundance of organisms is critical in
determining disease. Evidence from high-sensitivity techniques, limits the role of fungi in CRS to a small group of
patients. Comparison with molecular analysis suggests that the detection threshold of FISH and culture is related to
organism abundance and, furthermore, culture tends to select for rapidly growing organisms.Background
Chronic rhinosinusitis is a disease cluster with a signi-
ficant societal burden, and despite extensive research
efforts, has an unknown pathophysiology. There is emer-
ging evidence that microorganisms play an important role
in the exacerbation and perpetuation of mucosal inflam-
mation. However, the microbial biodiversity in disease and
controls is not well defined. Furthermore, the importance
of microorganism abundance, and potential relationship
to disease manifestation is unknown. To further our
understanding of the role of microorganisms in CRS, it is
important to comprehensively characterize the resident* Correspondence: peterj.wormald@adelaide.edu.au
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reproduction in any medium, provided the ormicrobial community in healthy and diseased tissue and
examine the specific host immunological responses to
these organisms. Thus, we sought to characterize the
microbial populations in CRS and controls to establish a
basis for further species directed research into this hetero-
geneous disease. Only through such a systematic approach
can we determine the importance, or otherwise, of these
microorganisms in the disease phenotypes. Furthermore,
comparative microbiome studies will provide important
information for the selection of antimicrobial therapies,
and enable the determination of the effectiveness of such
treatments.
Increasingly, we are discovering that complex poly-
microbial communities exist, especially at the host-
environment interface such as mucosal surfaces, and the
majority of these bacterial species are refractory to culture
[1]. Many of these organisms are found to be residing in
complex communities known as biofilms; communities oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ccharide matrix, irreversibly attached to a live or inert
surface [2]. There have been recent advances in our
understanding of biofilms in CRS, and their importance
regarding disease evolution following treatment [3], in-
creased postoperative infection [3], and altered host
immune mechanisms [4]. Many biofilm organisms are
resistant to culture [5], and their detection requires
specialized techniques [6]. Phenotypic differences which
occur between planktonic and biofilm based organisms,
may contribute to the relative incapacity of biofilm associ-
ated organisms to grow on nutrient media [7,8].
Traditional culture-dependant techniques have been
the mainstay of microbial diagnostics in CRS. However,
the reliance of cultivation on nutrient media often re-
sults in ‘enrichment bias’ with detection of a narrow
range of microbes which is not representative of the
actual diversity present, particularly in environmental
samples [9]. Competition between organisms during
enrichment often results in dominance of one or two
organisms with the fastest growth rates [9]. Selective
media techniques use nutrient restriction to enhance or
restrict growth of organisms based on inherent microbial
characteristics for identification. In a complex microbial
community such as the diseased sinonasal mucosa, the
identification of every organism using this method
would be exhaustive. Additionally, many organisms may
not thrive on nutrient media once the advantages of bio-
film structures, and symbiotic relationships are lost.
The objective of this study was to determine the
relationship between disease manifestation, and the bio-
diversity and abundance of mucosal microorganisms in
CRS patients and controls using broad-based molecular
diagnostics and conventional culture. Additionally, we
sought to determine the specificity of contemporary
biofilm detection methods by comparing them with
molecular detection techniques in the same patients.
Whilst our understanding of the importance of these
communities in CRS, and their capacity to benefit or harm
the host is in it’s infancy, the investigation is fundamental
to furthering our understanding of this disease.
Methods
This prospective study was undertaken in the tertiary
referral rhinology practice of the senior author (PJW), at
the academic hospitals, Adelaide, South Australia. The
study was approved by the Ethics of Human Research
Committee, The Queen Elizabeth Hospital, South
Australia, and 44 consecutive patients provided in-
formed consented to involvement in the study. 38
patients met the definition of CRS as defined by the
rhinosinusitis taskforce [10] having failed medical the-
rapy necessitating the need for endoscopic sinus surgery
(ESS). A control group consisted of 6 patients who hadno clinical or radiological evidence of sinus disease.
These patients were undergoing transnasal endoscopic
procedures including trans-sphenoidal hypophysectomy
for non-functioning adenomas (5 patients) or CSF leak
repair (1 patient). Patients were excluded if less than 18
years of age, immunocompromised, or had decreased
ciliary function such as cystic fibrosis and Kartagener’s
syndrome. Other exclusion criteria included inadequate
mucosa for analysis, no fungal or bacterial culture
taken, and antibiotic or systemic corticosteroid used in
the three weeks preceding surgery.
Tissue collection
CRS patients had sinus mucosal tissue harvested from
the ethmoid sinuses during ESS. Control patients had
mucosa harvested from the posterior ethmoid and
sphenoid as required to access relevant skull base path-
ology. Tissue was immediately stored in Dulbecco’s
modified Eagle medium (Gibco, Invitrogen Corp., Grand
Island, NY) without antibiotic or antimycotic, and
transported on ice to the laboratory for further analysis.
Mucus was harvested for histopathological examination,
and for routine bacterial and fungal culture. In the ab-
sence of mucus, a middle meatal swab was taken for
bacterial and fungal culture.
Bacterial & fungal culture
Intraoperative swabs were transported to the laboratory
(Oxoid Transport Swabs, Thermo-Fischer Scientific,
Scoresby, Australia) and were streaked onto Columbia
horse blood agar, and Chocolate agar (Thermo-Fisher
Scientific). Fungal swabs were inoculated onto Sabouraud
agar (Thermo-Fisher Scientific). Further nutrient res-
triction and testing was performed as required for
identification.
Biofilm analysis
Fluorescence in-situ hybridization (FISH) was performed
on mucosa that had been stored at −80°C. Cryopreserva-
tion prior to FISH analysis of sinus mucosa has been
validated in our department [11]. Defrosted samples were
washed thoroughly in MilliQ water prior to hybridization
to remove planktonic organisms. Two probes were uti-
lized on separate pieces of mucosa - a S. aureus specific
16S sequence conjugated to Alexa-488 probe, and a pan-
fungal 18S Alexa-488 probe. (AdvanDx, Woburn, MA).
The manufacturer’s protocol was followed. Briefly, sam-
ples were fixed to glass slides, dehydrated in 90% ethanol,
air dried, and hybridized at 55°C for 90 minutes. Samples
were transported to Adelaide Microscopy for analysis
using the Leica TCS SP5 Confocal Scanning Laser Micro-
scope (Leica Microsystems, Wetzlar, Germany). An excita-
tion of 488 nm with emission range of 495 – 540 nm was
used to detect S. aureus and fungus. The entire sample
Table 1 Demographic & clinical data
CRS Controls
Number 38 6
Age* 41 (35–47) 44 (37–54)
Male/Female 22/16 2/4
Nasal polyposis (%) 25 (66%) 0
Lund-MacKay CT Score* 17 (15–20) 0
Revision Surgery (%) 25 (66%) 0
Smoking 2 (5%) 0
Aspirin Sensitivity 3 (8%) 0
Asthma 10 (26%) 1 (17%)
* Mean (Interquartile range).
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stacks (0.5 μM) were recorded of representative areas to
construct a three dimensional virtual images of the tissue,
overlying mucus and biofilm.
DNA extraction
An 8 × 8 mm square of mucosa was carefully dissected
for each patient using sterile instruments under laminar
flow conditions and stored at −80°C prior to DNA
extraction. A 1 mm [3] piece of this tissue was placed
into a sterile microcentrifuge tube containing 270 μL of
ATL Lysis buffer (Qiagen, Germantown, MD, cat#
19076) and 30 μL proteinase K (Qiagen, cat# 19131).
Samples were incubated at 56°C until lysis of the mater-
ial was noted by visual inspection, then 100 μL of a
mixture containing 50 μL each of 0.1 mm and 0.7 mm
Zirconia beads (Biospec cat# 11079101z, 11079107zx
respectively) were added to the samples which were then
homogenized for 10 min at 25 Hz using a Qiagen
Tissuelyser. Nucleic acid from the lysed sample was then
extracted using the Qiagen DNeasy Tissue kit (Qiagen
cat# 69506). 10 μL of each sample was loaded per well
for both the Ibis Bacteria, Antibiotic Resistance, and
Candida (BAC) and Fungal detection PCR plates (Abbott
Molecular, cat# PN 05N13-01).
Ibis T5000 analysis - PCR coupled with electrospray
ionization mass spectrometry
The BAC detection plate contains 16 PCR primer pairs
that collectively survey all bacterial organisms by using
both omnipresent loci (eg. 16S rDNA sequences), as well
as more taxa-specific targets (eg. the Staphylococcus-
specific tufB gene) as well as providing coverage for
major antibiotic resistance genes and Candida. The fun-
gal detection plate also uses 16 PCR primer pairs that
collectively survey nearly all pathogenic fungal species.
An internal calibrant consisting of synthetic nucleic acid
template is also included in each well for both assays
which controls for false negatives (eg. from PCR inhibi-
tors) and enables a semi-quantitative analysis of the
amount of template DNA present. PCR amplification
was carried out as per Jiang and Hofstadtler [12]. The
PCR products were then desalted in a 96-well plate for-
mat and sequentially electrosprayed into a time-of-flight
mass spectrometer. The spectral signals were processed
to determine the masses of each of the PCR products
present with sufficient accuracy that the base compos-
ition of each amplicon could be unambiguously deduced
[13]. Using combined base compositions from multiple
PCRs, the identities of the pathogens and a semi-
quantitative determination of their relative concentra-
tions in the starting sample were established by using a
proprietary algorithm to interface with the Ibis database
of known organisms.Statistical analysis
Demographic data and species data where appropriate
were reported as the mean +/− interquartile range. The
Kruskal-Wallis test was used to compare multiple
groups with Dunn’s post hoc test for non-parametric
data. Sensitivity and specificity are presented with upper
and lower 95% confidence intervals (CI). Genomes per
sample are presented as mean (lower – upper 95% CI),
and analysed using The Mann–Whitney U test.
GraphPad Prism software (San Diego, CA) was used for
statistical analysis, and a p-value of 0.05 was considered
significant.
Results
The majority of CRS patients had relatively severe dis-
ease on radiologic scoring, 66% had polyposis, and the
majority were undergoing revision endoscopic sinus sur-
gery, reflecting the tertiary nature of the surgical practice
(see Table 1).
Number of species detected
Molecular organism detection using the Ibis T-5000 was
positive in 100% of CRS patients and controls. A total
of 33 different bacterial species were identified in CRS
patients by the Ibis system, with a mean of 3.0 (2.0-4.0)
species detected per patient (see Additional file 1: Table
S1). In control patients, 5 different organisms were detected
with a mean of 2.0 (1.0-3.0) per patient. There was a trend
of increasing mean isolates per patient from controls 2.0
(1.0-3.0), CRS without nasal polyposis (CRSsNP) 2.5
(1.0-3.0), to CRS with nasal polyposis (CRSwNP) 3.2
(2.0-4.0) but this was not statistically significant (p > 0.05,
Kruskal-Wallis test, Dunn’s post-hoc comparison). Ibis ana-
lysis detected fungi in only 4 CRSwNP patients, and no
fungi were detected in CRSsNP patients or controls.
Conventional culture was positive in 73% of CRS
patients, with an average of 1.3 organisms per patient
detected. 12 different organisms were identified. Cul-
tures were positive from 33% of control patients. Only
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from this subject group.
Diversity
30/38 (79%) CRS patients, and 3/6 (50%) of control
patients, had more than one bacterial species detected
on the mucosa using the Ibis molecular diagnostic.
Staphylococcus aureus was the most commonly detected
organism in CRS patients (23/38, 61%), followed by
Staphylococcus epidermidis (21/38, 55%), and Propioni-
bacterium acnes (14/38, 37%, see Table 2). Nocardia
asteroides (9/38, 24%), Haemophilus influenzae (5/38,
13%) and Pseudomonas aeruginosa (3/38, 8%) were
detected less commonly. In control patients, Propionibac-
terium acnes was the most commonly detected organism
(5/6, 85%), followed by Staphylococcus epidermidis,
present in 4/6 (67%) of patients. Less commonly detected
were Staphylococcus aureus 2/6 (33%), Nocardia
asteroides 1/6 (17%) and Streptococcus agalactiae 1/6
(17%). Anaerobic species were detected in 18/38 (47%) of
CRS patients, and 5/6 (83%) of control patients.
Conventional cultures produced polymicrobial results
in 21/38 (55%) CRS patients, whereas no control
patients had polymicrobial flora using this method. CRS
patients yielded predominantly S. aureus (14/38) and
Staphylococcus epidermidis/coagulase-negative Staphylo-
coccus (CNS) (11/38). Only Staphylococcus epidermidis/
CNS was cultivated from 2 control patients. No growth
was reported for 9/38 CRS patients, and 4/6 control
patients.
Fungi were rarely detected in CRSwNP patients regard-







Staphylococcus aureus 23 (61%) 10549
Staphylococcus epidermidis 21 (55%) 508
Propionibacterium acnes 14 (37%) 2339
Nocardia asteroides 9 (24%) 1587




Streptococcus agalactiae 4 (11%) 57
Moraxella catarrhalis 3 (8%) 2931
Pseudomonas aeruginosa 3 (8%) 1852
Streptococcus pneumoniae 3 (8%) 1908
Mean microbial genomes per patient
sample all detected organisms
(lower - upper 95% CI)
870 (605–1136)patients or controls. Analysis with the Ibis biosensor
showed only two species - Aspergillus fumigatus (3), and
Bipolaris papendorfii (1). Culture detected only two of the
Ibis fungal positive patients (both Aspergillus fumigatus)
plus one Penicillium chrysogenum, and one Trichosporon
in other patients, which were not detected by the biosen-
sor. Fungal-specific FISH analysis was positive in the three
A. fumigatus patients detected by the Ibis biosensor, the P.
chrysogenum culture-positive patient, and two additional
patients, which were negative by the other techniques.
Regardless of detection technique, all patients in whom
fungi was detected had nasal polyposis.
Detection of S. Aureus using ibis biosensor, FISH, and
culture
We used S. aureus as a model organism for studying the
characteristics of the three different detection methods.
The biosensor detected S. aureus in 61% of CRS pa-
tients, biofilm was positive in 50% (see Figure 1), and
conventional culture was positive in 37%. FISH analysis
had a sensitivity of 78% (±18) for the detection of S.
aureus compared to Ibis, with a specificity of 93% (± 6).
In contrast, conventional culture detected S. aureus with
a sensitivity of 61% (±17), and a specificity of 93% (+16).
S. aureus was detected in control patients only by
molecular detection (2/6, 33%). Neither conventional
culture nor FISH analysis was positive for S. aureus in
these patients.
Relative microbial density
We determined the relative numbers of the bacterial spe-











459 2 (33%) 101 51
24 4 (67%) 21 5
167 5 (83%) 621 124
176 1 (17%) 72 72
81 - - -
530 - - -
14 1 (17%) 3 3
977 - - -
617 - - -
636 - - -
136 (−32 - 303)
Figure 1 Staphylococcus aureus FISH probe tagged with Alexa
488, analyzed with confocal scanning laser microscopy at 80×
magnification.
Figure 2 The relationship between S. aureus abundance, and
detection by FISH and culture. The detection of S. aureus by FISH
and culture is dependant on the abundance of the bacteria as
measured by the number of bacterial genomes present in
the sample.
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in Table 2. The most commonly detected organisms in
CRS patients, S. aureus and S. epidermidis, had markedly
different microbial densities, with S. aureus organisms
present in much higher numbers than S. epidermidis
based on bacterial genomes detected. Some of the less
commonly detected organisms such as Corynebacterium
pseudodiphtheriticum, Moraxella catarrhalis, Streptococcus
pneumoniae, and Pseudomonas aeruginosa, were found in
relatively high numbers when detected on the mucosa. The
abundance of S. aureus was much greater in CRS patients
compared to controls, however other organisms such as S.
epidermidis and P. acnes were detected in similar quantities
in both patient groups. When all organisms were consi-
dered, CRS patients had significantly greater bacterial
genomes per sample than control patients (p < 0.05, Mann–
Whitney U test - see Table 2).
Are FISH and culture detection related to microbial
abundance
We again used the organism S. aureus to compare detec-
tion techniques based on microbial numbers. The quanti-
tative genomic analyses of the 25 (CRS and control)
samples in which S. aureus was detected by the Ibis bio-
sensor, were compared to the detection of the organism
by FISH and conventional culture to determine if these
latter detection methods are dependent on the abundance
of organisms to provide a positive finding (see Figure 2).
The number of S. aureus genomes per sample was signifi-
cantly higher in those specimens that tested positive for
S. aureus by FISH and conventional culture (p < 0.05,Kruskal-Wallis test, Dunn’s post-hoc comparison). How-
ever there was no statistically significant difference be-
tween FISH and culture detection sensitivity based on S.
aureus genomes per sample (p > 0.05, see Figure 1).Discussion
This study compares the microbial bioburden in CRS
patients, with healthy controls using three markedly dif-
ferent, but complementary detection techniques. We
have shown that conventional laboratory culture has a
tendency to polarize the detected microbes, selecting for
abundant, rapidly growing aerobic organisms with
favourable growth characteristics, such as S. aureus and
S. epidermidis. Biosensor molecular detection allows a
more comprehensive analysis of the microbial commu-
nity and has the advantage of not requiring a priori
knowledge of the flora. S. aureus was the most com-
monly detected organism in CRS patients, and was rela-
tively more abundant in CRS patients compared to
controls. It was detected with high sensitivity with FISH
compared to the biosensor, but at lower levels by
conventional culture. We have shown that molecular
quantification can provide additional information with
respect to microbial abundance, and comparisons be-
tween health and disease may assist our understanding
of the role of these organisms in pathogenesis. Additio-
nally we have shown that the detection of organisms
using FISH and conventional culture is significantly
dependant on microbial abundance as measured using
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monly, in a select group of nasal polyp patients.
Staphylococcus aureus was the most prevalent organ-
ism in CRS patients using molecular detection, followed
by Staphylococcus epidermidis and Propionibacterium
acnes. When the microbial density was compared for
these three organisms between CRS and control pa-
tients, S. aureus was present at approximately 10 times
higher genomes per sample in CRS patients, whereas S.
epidermidis and P. acnes were found in similar abun-
dance between both patient groups. The increased
bioburden of S. aureus in the disease group is of particu-
lar interest, as it is emerging as a prominent disease
modifying organism in CRS and it’s presence in patients
has important clinical implications [14,15]. The capacity
of S. aureus to exist within dense mucosal biofilms has
been documented [11,16], which may explain the vari-
able detection from clinical specimens using traditional
culture techniques.
A multitude of other studies have recently reported
CRS microbiological data using a variety of techniques,
including molecular diagnostics and FISH. Comparison
with these studies is of interest to further our under-
standing of this disease. In the current study, Haemophi-
lus influenzae was detected at relatively low levels (13%)
in CRS patients, and was not detected in controls. This
is in agreement with Stephenson et al., who detected H.
influenzae in 17% of CRS patients [17], but contrasts
with earlier FISH based studies which proposed it as the
dominant organism in CRS [18,19]. Pseudomonas
aeruginosa was also found infrequently in the current
study (8%), confirming the findings of Stephenson et al.
These results contrast with a recent molecular study
which found P. aeruginosa to be the dominant organism
in CRS patients, however control patients were not
assessed [20]. The disparity in organism profiles between
studies may reflect regional variation, patterns of anti-
microbial use, methodological differences, or disease se-
verity patterns.
The disease burden in the current study was relatively
high as measured by the radiological severity and the
rate of non-primary surgery, which were at least twice as
high as others [17,20], reflecting the tertiary nature of
the practice. Some microbial biofilms have been associ-
ated with a more severe disease process than others [16],
and the microbial community in this study may reflect
some bias towards the more severe end of the CRS
spectrum. However, this is arguably the population
which is most resistant to current treatment paradigms,
and therefore of utmost importance to investigate.
The high prevalence of anaerobes detected in CRS pa-
tients is in agreement with previous molecular studies
[17,20], however we also found high rates in controls,
with similar abundance, casting doubt on a directpathogenic role. There was poor agreement between the
Ibis biosensor and conventional culture data for anaer-
obes, which reflects the paucity of culture-based studies
reporting anaerobic species in CRS. These different de-
tection methodologies seem to have comparable efficacy
at detecting abundant, fast growing organisms. The
pathologic importance of these species remains to be de-
termined however.
Through the use of molecular detection we are begin-
ning to understand the natural flora of non-diseased
sinuses. Contrary to previous reports of sterility [21,22],
we have shown that all healthy sinuses in this study are
associated with a microbial community, and many of
these organisms are also found in diseased sinuses.
Nevertheless, we have shown that the abundance of
organisms is significantly greater in CRS patients com-
pared to controls - a phenomenon which requires
further investigation with greater numbers of patients.
The cultivation of microorganisms using traditional
culture has many pitfalls which may explain it’s limited
utility in describing polymicrobial communities such as
that within diseased sinuses. To be detected, organisms
must grow on media after being removed from the na-
tive mucosal surface, with significant environmental
changes in temperature, pH, nutrient sources, and with-
out the complex dynamics of polymicrobial communities
and host immune systems. Molecular methods such as
the Ibis biosensor offer great potential for analysis of
microbial diversity in CRS, which is untempered by the
limitations of conventional culture. Molecular methods
are sensitive and accurate and provide a more complete
view of the bacterial communities present, and even
provide a molecular antibiogram to guide treatment
decisions. An important caveat however, is the capacity
of molecular techniques to detect the genetic material of
non-viable microorganisms. This must be taken into
consideration when comparing between these, and
culture-based techniques. Access to molecular detection
instrumentation and expertise may also limit it’s utility
in the clinical setting, but this is rapidly improving.
The formation of biofilms also impacts on the culture
rates from patients. Organisms that form these immo-
bilized consortia often undergo phenotypic transforma-
tions with reduced metabolic activity, which impacts the
capacity to grow on selective media [2]. Using the model
organism S. aureus, we have shown significantly in-
creased detection rates using both FISH and molecular
detection compared to cultivation techniques. Similar to
previous studies [11,23,24], biofilm was not detected in
the control patients, despite detection of S. aureus in 2/6
controls by the Ibis biosensor. In situ hybridisation tech-
niques have previously been reported to have reduced
sensitivity in detecting low copy number nucleic acids of
scarce bacteria [1]. In an attempt to counter this, we
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has higher affinity and stability for microbial DNA se-
quences than conventional FISH probes [25]. Despite
this however, some of the CRS patients, and both
controls with S. aureus detected at low DNA copy num-
ber by Ibis, were not detected by FISH. This limitation
not with standing, we have shown a good correlation
between FISH and biosensor detection of S. aureus in
CRS patients, with high sensitivity and specificity,
suggesting it has good clinical and research applicability.
The prevalence of fungi in CRS and healthy control
patients has long been debated [26]. Many studies have
found a predominance of fungi in both patient groups
when the nasal cavity is sampled [27-29]. It is possible
that these studies are detecting inhaled environmental
fungi, which is trapped within nasal mucus en-route to
the oropharynx. When sinus mucosa is specifically
analysed, studies suggest a lesser prevalence in CRS pa-
tients and absence in controls [30,31]. The charac-
terization of fungal species in CRS is far less advanced
than for bacteria, and whether or not certain fungal
species are more prevalent or important in CRS is still
unknown. Therefore we employed a pan-fungal FISH
probe to detect all species, in conjunction with culture
and molecular detection. We found fungi in a small
proportion of the sinus mucosa of CRS patients using all
three detection methods, and an absence in control
patients. The three methods showed similar sensitivity.
Fungi may be playing a role in this small subset of CRS
patients, all of whom had nasal polyposis. This study
refutes the theory that current culture methods are
insensitive and missing a large proportion of patients in
whom fungi are playing a central role.
The importance of understanding the complex poly-
microbial communities in the sinuses is highlighted by
the concept of dysbiosis, where organisms interact in
positive (mutualistic) or negative ways to alter the local
community, and interaction with the host. There is
evidence to suggest that microbial diversity is important
for health [32], and a reduced diversity with increased
abundance is associated with chronic inflammation and
poor healing [33]. There is also literature to suggest that
host genetics and immunity strongly influence the
composition of the mucosal microflora [34]. Microbial
communities inhabiting mucosal surfaces such as the
gastrointestinal tract can result in a significant mutua-
lism including local immune homeostasis [35,36], and
protection from pathogens through processes such as
nutrient consumption, occupation of attachment sites,
and secretion of antimicrobial substances [37]. Propioni-
bacterium acnes, which was found in more than 80% of
control patients in the current study, has been shown to
produce bacteriocins which have antibacterial and
antifungal activity which may be protective againstpathogens [38]. Competition between microbes on mu-
cosal surfaces can result in selection of virulence factors
which can be detrimental to the host [39]. In an elegant
model of polymicrobial interactions, Sibley et al., have
shown that avirulent organisms can enhance the patho-
genicity of other organisms, highlighting the importance
of comprehensive community analysis to investigate dis-
ease [40].
It is possible that disruption of mutualistic relation-
ships, through shifts in mucosal-associated microbial
composition, could contribute to the onset, progression,
or recalcitrance of CRS. For example, the change in
microbial dynamics during a viral upper respiratory tract
infection or acute bacterial exacerbation of CRS. The
often protracted use of antibiotics in our patients may
also have detrimental sequelae on the microbial balance
in CRS which requires further substantiation. There is
poor understanding of such mechanisms in CRS, but
they are an active focus of research at present. The first
step in this journey is to greatly improve our knowledge
of the mucosal microbial communities in CRS patients
and controls.
Future directions for research should examine larger
populations of CRS patients to characterize the micro-
biome of the different CRS phenotypes in comparison
with healthy controls. Other molecular techniques, such
as 16S rRNA gene pyrosequencing and quantitative real-
time PCR will provide greater resolution for more detailed
microbiome studies. Furthermore, longitudinal molecular
studies evaluating the effect of antibiotics, endoscopic
sinus surgery, and topical treatments on microbial diver-
sity and abundance in CRS patients would be invaluable.
Investigating the relationships within the microbial com-
munities, and their interactions with the host immune
system in health and disease, will ultimately lead to a
greater understanding of the pathogenesis of chronic
rhinosinusitis.
Conclusion
This study has demonstrated some important hallmarks
regarding the microbiome of chronic rhinosinusitis, and
control sinuses. The healthy sinus is not sterile, and it
appears that not only prevalence, but also abundance, of
organisms is critical in determining the disease state.
Comparison with molecular analysis suggests that the
detection threshold of FISH and culture is related to
organism abundance and, furthermore, culture tends to
select for rapidly growing organisms.
Additional file
Additional file 1: Table S1. Ibis Microorganism detection, CRSwNP =
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